Management of open-angle glaucoma after the LIGHT trial: what is the role of hospital optometri...

26 November 2019
Volume 20, Issue 4
Glaucoma

This article outlines the laser treatment modalities for glaucoma and ocular hypertension.

Glaucoma, including primary open-angle glaucoma, is a leading cause of visual loss in the UK and around the world. Considered in the context of the optometrist’s role in glaucoma care, this article outlines the laser techniques used to treat the condition, together with the results of a new treatment study, the Laser in Glaucoma and Ocular Hypertension (LiGHT) trial.

Sign in to continue

Forgotten password?
Register

Sign in to view the article

Not a member? Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Join the College today

Related further reading

College calls for glaucoma care shift by fully unlocking safe and effective primary care capacity

Glaucoma is the second leading cause of irreversible sight loss in the UK and affects over one million people, which is predicted to rise by 100,000 cases to 1.145 million people by 2030*.

Glaucoma Models of care Public health Workforce

Top five skills to strengthen your clinical confidence

This year’s Optometry Tomorrow programme is designed to help you grow the skills that make the biggest difference in practice.

Contact lenses Glaucoma Retina Workforce

A leaner, smarter year for eye care

Chris Steele FCOptom, Clinical Editor of Acuity, wants to make 2026 smarter and leaner

AI and technology Glaucoma OCT Public health